Urist Marshall
CIK 0001838139
EVP, Research & Investments
Filings
24
Latest May 21, 2026
Issuers covered
1
Showing
24 of 24
Page 1
Track record
15 of 17 open-market trades scored (88% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 15 | 47% | -3.4% | -1.3% | +4.6% | -14.8% |
| 90 days | 15 | 13% | -15.3% | -19.0% | +11.0% | -25.0% |
| 180 days | 7 | 29% | -18.2% | -36.7% | +20.2% | -38.4% |
| 365 days | 3 | 100% | +21.5% | +17.5% | +30.5% | +16.5% |
Issuers
Companies where Urist Marshall has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| RPRX | Royalty Pharma PLC | 24 | May 21, 2026 |
All filings
24 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|